SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015656
Filing Date
2021-11-12
Accepted
2021-11-12 08:00:41
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 2053355
2 EX-31.1 tmb-20210930xex31d1.htm EX-31.1 16519
3 EX-31.2 tmb-20210930xex31d2.htm EX-31.2 13536
4 EX-32.1 tmb-20210930xex32d1.htm EX-32.1 7670
5 EX-32.2 tmb-20210930xex32d2.htm EX-32.2 7048
  Complete submission text file 0001558370-21-015656.txt   6532621

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210930.xsd EX-101.SCH 42125
7 EX-101.CAL tmb-20210930_cal.xml EX-101.CAL 36624
8 EX-101.DEF tmb-20210930_def.xml EX-101.DEF 203693
9 EX-101.LAB tmb-20210930_lab.xml EX-101.LAB 296373
10 EX-101.PRE tmb-20210930_pre.xml EX-101.PRE 313105
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 1091892
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 211399690
SIC: 2834 Pharmaceutical Preparations